News summary

Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation

Source: Frontiers - Health • Published: 09 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Liver-eye axis research linking fatty liver and diabetic retinal disease using genetic, proteomic, and single-cell approaches; a multi-modal mechanistic investigation.

Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation
Key Takeaways
  • Mendelian randomization tested causal relationships between NAFLD genetic liability and diabetic retinopathy stratified by non-proliferative and proliferative stages.
  • Proteome-wide MR across three blood pQTL datasets identified circulating proteins associated with genetic risk for diabetic retinopathy.
  • Follow-up analyses included colocalization, mediation testing, single-cell sequencing, and clinical sample validation to prioritize liver-derived mediators.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?